Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Ordinary shares
-
Shares outstanding
-
49,942,911
-
Total 13F shares
-
17,133,052
-
Share change
-
+653,357
-
Total reported value
-
$586,618,000
-
Price per share
-
$34.24
-
Number of holders
-
45
-
Value change
-
+$22,048,630
-
Number of buys
-
18
-
Number of sells
-
20
Institutional Holders of Immunocore Holdings plc - Ordinary shares (IMCR) as of Q4 2021
As of 31 Dec 2021,
Immunocore Holdings plc - Ordinary shares (IMCR) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,133,052 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Rock Springs Capital Management LP, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, RTW INVESTMENTS, LP, Avidity Partners Management LP, GENERAL ATLANTIC, L.P., Bain Capital Public Equity Management II, LLC, FIRST MANHATTAN CO, and BlackRock Inc..
This page lists
45
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.